Medications ·

Airway Maintenance Medicines and an Antibiotic Contrast

Not marked readNot yet practiced

Estimated study time. Take the time you need.

Introduction

Some breathing medicines prevent trouble before it starts. Others stop trouble that has already started. An antibiotic does something different again: it treats an infection caused by bacteria. Much of a pharmacy technician's safety work is noticing when someone treats one kind of medicine as if it were another.

This lesson uses five representative medicines: budesonide and fluticasone (inhaled corticosteroids), montelukast (a leukotriene blocker), tiotropium (a bronchodilator), and azithromycin (a macrolide antibiotic). It is not a complete list of airway or antibiotic medicines.

By the end of this lesson, you should be able to:

Name the class of each representative medicine and describe its main use in plain words.
Explain why the four airway maintenance medicines are not used to stop a sudden breathing attack.
Contrast an antibiotic course with ongoing maintenance use.
Spot product, route, device, interaction and warning details that need a pharmacist or emergency help.

Before you start: You need everyday reading and simple division. It helps to have read Read a medicine identity before learning a name, but every term used here is defined when it first appears.

Three different jobs: prevent, rescue, treat infection

Picture an airway as a tube that air must pass through. Breathing gets harder if the tube's lining becomes swollen and irritated, or if the tube tightens.

A maintenance medicine (also called a controller) is used on a regular schedule to keep symptoms from building up. It is like keeping a path clear every day so it does not get blocked. A rescue medicine (acute-relief medicine) is used when symptoms are already happening. The prescriber decides which product fills that role. The sources for this lesson call it a "short-acting" or "fast-acting" inhaler.

An antibiotic has a different target. It works against bacteria, not against swelling or a tight airway.

The rest of the lesson builds on one causal question: what does this medicine actually do, and how fast? The answer explains why a product can help breathing over time and still be the wrong thing to reach for during an attack.

Inhaled corticosteroids: calm the airway lining over time

Inhaled corticosteroid means a corticosteroid medicine breathed in by mouth so it reaches the airways. Corticosteroid is the class name. In plain words, it reduces swelling and irritation in the airway lining, so air can move more easily.

Budesonide and fluticasone are both in this class. MedlinePlus describes both inhaled forms as used to prevent difficulty breathing, chest tightness, wheezing and coughing caused by asthma. Asthma is a long-term condition in which airways can become swollen and narrowed.

Why "prevent" fits the mechanism: Calming a swollen lining takes time. For fluticasone, symptoms may improve within about 24 hours, but the full benefit may take 2 weeks or longer. For budesonide powder, full effects may take 1 to 2 weeks of regular use. For budesonide nebulizer suspension, they may take 4 to 6 weeks. A medicine that builds its effect over days or weeks cannot be counted on to open an airway in the next few minutes. Both monographs say the same: these medicines help prevent asthma attacks but will not stop an attack that has already started.

What follows from that: Because these medicines control asthma without curing it, the instructions say to keep using them even when the patient feels well, and not to stop without talking to the doctor. Feeling well is the expected result of the medicine working. It is not a sign the medicine is no longer needed.

Same ingredient does not mean same product

Budesonide shows why an ingredient name alone is not enough. MedlinePlus describes two inhaled budesonide forms:

Powder for oral inhalation (associated with the brand Pulmicort Flexhaler) is inhaled from a hand-held inhaler. It is used in adults and children 6 years and older. A new inhaler must be primed before its first use, and the patient should mention any milk-protein allergy.
Suspension for oral inhalation (associated with Pulmicort Respules) is a liquid in single-use containers called ampules. It is used with a jet nebulizer, a machine that turns the liquid into a mist to breathe in. It is used in children 12 months to 8 years old. It must not be swallowed, and other medicines must not be mixed into the nebulizer reservoir.

The two forms share one ingredient but differ in age range, device, timing of full effect and storage. Unused ampules must be thrown away 2 weeks after the foil pouch is opened, and the nebulizer solution must not be refrigerated or frozen.

Budesonide also appears in Symbicort, a combination product that also contains formoterol. A combination product is a different product, not "budesonide with another name."

Fluticasone works the same way. It comes as an aerosol and as a powder, and it is used once or twice daily depending on the specific product. The schedule belongs to the exact product, not to the ingredient.

Brand names in this lesson are associations that help you recognize products. They are not claims about what is on the market now. MedlinePlus flags some listed brand products as no longer marketed.

Question 1

A prescription is written for budesonide inhalation suspension for a 3-year-old. A coworker says, "Budesonide is budesonide. The powder inhaler on the shelf is the same drug, so it can be swapped in." Based on what you've learned, what is wrong with that reasoning?

Show answer and explanation

The powder and the suspension share an ingredient but are different products. MedlinePlus lists the powder for ages 6 and older with a hand-held inhaler. The suspension is listed for children 12 months to 8 years with a jet nebulizer. A 3-year-old falls in the suspension's age range, not the powder's.

The tempting mistake is to treat the ingredient name as the whole identity of the product. Form, device, age range and directions all come with the specific product. Changing the product is not a technician's decision. It goes to the pharmacist.

A leukotriene blocker: montelukast prevents, by mouth

Montelukast is in a class called leukotriene receptor antagonists (LTRAs). In plain words, it blocks the action of certain substances in the body that cause asthma and allergy symptoms. Unlike the other airway medicines in this lesson, it is taken by mouth, as a tablet, a chewable tablet or granules. It is not inhaled.

MedlinePlus lists several uses, and some details change with the use:

Preventing asthma symptoms in adults and children 12 months and older. For asthma, it is taken in the evening.
Preventing breathing difficulty during exercise in people 6 years and older. For this use, it is taken at least 2 hours before exercise. Someone already taking it daily, or who took a dose in the past 24 hours, should not take an extra dose before exercising.
Treating allergy-related nose symptoms (allergic rhinitis: sneezing and a stuffy, runny or itchy nose). This use is limited to people who cannot be treated with other medicines.

The source also states a firm limit: no more than one dose of montelukast in 24 hours.

Why the timing changes: For daily asthma control, the goal is steady prevention. For exercise, the goal is protection during a planned activity, so the dose is timed before it. The ingredient is the same, but the instructions follow the use.

Product details that matter:

The chewable tablets contain aspartame, which forms phenylalanine. That matters for someone with phenylketonuria (PKU), an inherited condition that requires a special diet.
The granules may be mixed only with certain listed foods or liquids, and the mixture must be used within 15 minutes.

Like the inhaled corticosteroids, montelukast is not for a sudden asthma attack. MedlinePlus says to keep taking it even when well and not to stop without talking to the doctor. There is one important exception, covered in the warnings section below.

Question 2

A patient taking montelukast once daily for asthma says, "I'm running a race this afternoon. I'll take another tablet a couple of hours before." Without giving advice yourself, what fact from the source makes this a question for the pharmacist?

Show answer and explanation

MedlinePlus says that someone taking montelukast daily, or who took a dose in the past 24 hours, should not take an additional dose before exercise. It also says not to take more than one dose in 24 hours. The patient's plan conflicts with that.

The technician's job is to recognize the conflict and bring in the pharmacist. The technician does not counsel the patient on what to do. The tempting mistake is to think that because exercise timing is a listed use, any extra dose for exercise is fine. The listed use comes with its own condition.

A bronchodilator that is still not a rescue medicine: tiotropium

A bronchodilator relaxes and opens the air passages to the lungs. Tiotropium is in this class. MedlinePlus describes it as used to prevent wheezing, shortness of breath, coughing and chest tightness in chronic obstructive pulmonary disease (COPD). COPD is a group of long-term lung diseases that includes chronic bronchitis and emphysema.

Many beginners assume "opens the airways" means "use it in an emergency." The source rules that out. It says not to use tiotropium for a sudden attack of wheezing or shortness of breath. It also says the full benefit may take a few weeks, and that the patient should keep using it even when feeling well. Here is the key lesson: class name alone does not tell you whether a product is a rescue product. A medicine can open airways and still be meant for steady daily prevention rather than fast relief.

The device is part of the product

Tiotropium comes as a capsule of dry powder used with a specially designed inhaler (associated with Spiriva HandiHaler). The details are strict:

Do not swallow the capsules. The route is inhalation.
Use the capsules only with the inhaler they come with, and never use that inhaler for any other medicine.
Open a capsule's blister package only right before use. Throw away a capsule whose package was opened by accident and can't be used right away.
Never store capsules inside the inhaler.
Keep the powder out of the eyes. Powder in the eyes can blur vision and cause light sensitivity, and the patient should call the doctor if that happens.
A new inhaler comes with each 30-day supply.

Question 3

Classify each medicine by class, and say whether MedlinePlus describes it for preventing symptoms or stopping a sudden attack: budesonide inhalation, montelukast, tiotropium.

Show answer and explanation

Budesonide is an inhaled corticosteroid. It prevents asthma symptoms by reducing airway swelling and irritation.
Montelukast is a leukotriene receptor antagonist taken by mouth. It prevents asthma symptoms and exercise-related breathing difficulty, and it treats certain allergic rhinitis symptoms.
Tiotropium is a bronchodilator. It prevents COPD symptoms.

The sources say none of the three is for stopping a sudden attack.

The trap is tiotropium. "Bronchodilator" sounds like rescue, but its monograph says it is not for sudden attacks. Classify by the product's described use, not by a guess from the class name.

Why these four are not interchangeable with a rescue medicine

Now combine the pieces. Ask what each product does, and how fast:

The inhaled corticosteroids calm airway swelling over days to weeks.
Montelukast blocks symptom-causing signals as a daily oral preventer.
Tiotropium opens airways as a daily maintenance product, with full benefit over weeks.

Each monograph says directly that the product will not stop, or should not be used for, an attack already under way. Each says the prescriber provides a separate short-acting medicine for attacks.

Change one fact and the answer changes. Suppose a patient uses fluticasone every morning and has no symptoms. The product is doing its intended job, and continuing as prescribed fits the label. Now change only one fact: the patient is wheezing right now and wants to take extra fluticasone. The medicine hasn't changed, but the situation has. An extra preventer dose is not what the label describes for an attack, and "use more or more often than prescribed" goes against the label.

The fluticasone and budesonide monographs also tell patients to call the doctor if an attack does not stop with the fast-acting medicine, or if they need the fast-acting medicine more than usual. A rising need for rescue medicine is itself a warning sign.

One more twist: both inhaled corticosteroids can sometimes cause wheezing and difficulty breathing immediately after inhaling. The monographs say to use the rescue medicine right away and call the doctor. So a breathing problem right after a maintenance dose is not proof that the patient needs "more of the same." It may be a reaction to the product.

Question 4

A patient in line says, "I use my fluticasone every day. I'm wheezing and having trouble breathing right now. Should I just take a few extra puffs?" What should the technician recognize, and what should happen next?

Show answer and explanation

The technician should recognize two things.

This is a possible emergency. The patient reports trouble breathing now. The American Heart Association lists difficulty breathing as a reason to call 911 immediately. Follow your site's emergency procedure and get the pharmacist at once.
The proposed plan conflicts with the product's label. Fluticasone will not stop an attack already under way, and taking more than prescribed goes against the label.

The technician does not choose a treatment or advise "extra puffs." The tempting mistake is to think a daily breathing medicine must help during an attack because it helps breathing in general.

The antibiotic contrast: azithromycin

Azithromycin is a macrolide antibiotic. It works by stopping the growth of bacteria. MedlinePlus says it treats bacterial infections, and it is also used to treat and prevent disseminated Mycobacterium avium complex (MAC), a lung infection that affects people with a weakened immune system.

Why it fails against colds and flu: Colds, flu and other viral infections are caused by viruses, not bacteria. An antibiotic's target is bacterial growth, so it has nothing to act on in a viral infection. MedlinePlus states that azithromycin will not work for those viral infections. It adds that using antibiotics when they aren't needed raises the risk of a later infection that resists antibiotic treatment. Azithromycin is also not a breathing medicine: it does not calm airway swelling or open airways.

"Keep taking it" means something different here

Both maintenance medicines and azithromycin tell patients to keep going when they feel better, but for different reasons:

Maintenance medicine: The condition is controlled, not cured. Use is ongoing, and stopping is discussed with the doctor.
Antibiotic course: The medicine is taken until the prescription is finished. Stopping early or skipping doses may leave the infection incompletely treated, and the bacteria may become resistant. The course has an end. MedlinePlus notes the prescription is probably not refillable, and says to call the doctor if infection symptoms remain after finishing.

So "keep taking it" points to a finished course for the antibiotic and to steady ongoing use for the controller.

Product and route details:

Azithromycin comes as a tablet and as a suspension taken by mouth. The suspension is shaken well and measured with a dosing spoon, oral syringe or measuring cup.
The single-dose 1-gram powder packet must be mixed with water before taking. The source gives specific mixing steps to make sure the whole dose is taken.
If the patient vomits within an hour of a dose, they should call the doctor. They should not take another dose unless the doctor says to.

Question 5

A customer with a stuffy nose and a cough says, "My cold is lasting forever. Can't I just use the leftover azithromycin from my last prescription? It's an antibiotic for breathing problems." Which two ideas from this lesson does this statement get wrong, and who handles the conversation?

Show answer and explanation

Azithromycin targets bacteria. MedlinePlus states it will not work for colds, flu or other viral infections. It is not a breathing medicine.
An antibiotic is meant to be taken as a finished course. The source says to take it until the prescription is finished. It is not something to keep and reuse later.

Deciding whether this customer's illness is bacterial is not a technician's job, and neither is recommending a treatment. An OTC recommendation or a question about whether a medicine fits a condition goes to the pharmacist.

Compare the neighboring classes

Each class answers a different question:

Inhaled corticosteroid answers: Is the airway lining swollen and irritated over time? It reduces that swelling with regular use.
Leukotriene blocker answers: Can blocking a symptom-causing signal, taken by mouth, prevent symptoms? Its timing depends on the use.
Bronchodilator answers: Can relaxing the airway muscles open the passages? Whether a particular bronchodilator is for daily maintenance or for rescue depends on the product. Tiotropium is maintenance.
Macrolide antibiotic answers: Is there a bacterial infection to stop? It has no role in airway swelling or tightness.

These are different tools, not different strengths of the same tool.

Device counts and arithmetic: useful, but not permission

Inhalers hold a labeled number of inhalations. The budesonide powder inhaler provides 60 or 120, depending on size. Fluticasone products provide 30, 60 or 120, depending on the type. MedlinePlus explains that you can estimate how long an inhaler lasts by dividing the labeled inhalations by the inhalations used per day. (For more practice, see Calculate days supply.)

Worked example (fictional; all assumptions supplied): A fluticasone product is labeled for 120 inhalations. The prescription directions, assumed for this example, are 2 inhalations twice a day.

Inhalations per day: 2 × 2 = 4.
Days the inhaler lasts: 120 ÷ 4 = 30 days.
Check by reversing: 30 days × 4 per day = 120 inhalations. ✓

Change one fact: Keep the same directions, but the product is labeled for 60 inhalations. Now 60 ÷ 4 = 15 days. The use per day didn't change, but the supply did, so the inhaler runs out twice as fast.

What the count means: After the labeled number of inhalations, later sprays may not contain the correct amount of medicine. The monographs say to throw the inhaler or canister away after the labeled number has been used, even if it still sprays. "It still sprays" is not evidence of a full dose.

Why correct arithmetic is not the finish line: Suppose the same calculation is perfect. The directions still say 2 inhalations twice a day, so the scheduled-use math still gives 30 days. But the directions also include an added instruction: "use as needed during asthma attacks." The 30-day figure applies only to the stated schedule. It does not establish a days supply for any as-needed attack use, because that instruction gives no frequency or maximum. More importantly, the added instruction conflicts with the product's own statement that it is not for attacks. That conflict goes to the pharmacist. A correct number does not authorize dispensing.

Other device rules are also product-specific:

The fluticasone aerosol inhaler is designed only for its fluticasone canister. It must not be used with other medicines, and fluticasone must not be used in any other inhaler.
The aerosol must be kept away from open flames and high heat, because it may explode.
It is stored with the mouthpiece pointing down.

These rules come from the fluticasone monograph. Do not assume they apply to every inhaler. Equipment details are covered further in Product-specific respiratory and injection equipment.

Question 6

A fictional budesonide powder inhaler is labeled for 60 inhalations. Assume the directions are 1 inhalation twice a day. How many days will it last? On day 31, the patient says it still releases powder and asks if they can keep using it. What does the source say about the count?

Show answer and explanation

Inhalations per day: 1 × 2 = 2.
Days the inhaler lasts: 60 ÷ 2 = 30 days.
Check: 30 × 2 = 60. ✓

By day 31, the labeled 60 inhalations have been used. MedlinePlus says later inhalations may not contain the correct amount, and the inhaler should be thrown away after the labeled number even if it still releases medicine.

The tempting mistake is to judge by what the device still does rather than by the labeled count. The patient's question about continuing use goes to the pharmacist.

Interactions: a listed interaction is not a known direction

An interaction is when one substance changes how another works or how safe it is. The sources list possible interactions without always explaining what happens:

Montelukast: The patient should be sure to mention gemfibrozil, phenobarbital and rifampin. The source says the doctor may need to change doses or monitor more carefully. It does not say which way any effect goes. Separately, if aspirin makes the patient's asthma worse, they should avoid aspirin and other NSAIDs while taking montelukast.
Tiotropium: The nonprescription product cimetidine may interact. The patient should not start it while using tiotropium without discussing it with a healthcare provider. The source does not describe the direction of the effect.
Azithromycin: Antacids containing aluminum hydroxide or magnesium hydroxide need some time between doses. The source tells patients to ask the doctor or pharmacist how many hours. It does not give the number.

The skill here is recognition, not prediction. A listed interaction tells you to bring in the pharmacist. It doesn't tell you, and you shouldn't guess, whether one drug raises or lowers the other or how far apart doses should be. More on this topic is in Duplication, interactions and contraindications.

Warnings that need a handoff, and those that need emergency help

The PTCE content outline lists issues that require pharmacist intervention. Among them are adverse drug events, OTC recommendations, therapeutic substitution, adherence, allergies and drug interactions. An adverse drug event is harm that happens while someone is using a medicine.

What the technician does in each case is shaped by the situation, by state law and by site procedure. The handoff steps in this lesson show the reasoning. They are not a state rule, and a national exam outline does not replace your state's rules on what technicians may do.

Warnings named in the sources

Montelukast mental-health warning. Montelukast may cause serious or life-threatening mental health changes, during treatment or after it has stopped. This can happen even in people with no past mental health problems. The listed symptoms include agitation, aggression, anxiety, confusion, unusual dreams, hallucinations, depression, sleep problems, sleepwalking, tremor, and suicidal thoughts or actions. MedlinePlus says to stop the medicine and call the doctor right away if these occur. This is the stated exception to "don't stop without talking to your doctor."

If suicidal thoughts or a life-threatening situation are involved, the NIMH says to get help as soon as possible. Call 911 in a life-threatening situation. The 988 Suicide & Crisis Lifeline (call or text 988) is also available.

Allergic-type reactions. Several of these medicines list hives, rash, itching, swelling of the face, throat, tongue or lips, and difficulty breathing or swallowing as serious. The American Heart Association lists severe allergic reactions and difficulty breathing as reasons to call 911 immediately.

The ACAAI explains that a true drug allergy involves the immune system, and that side effects are often mistaken for allergies. Recording what symptoms happened, and when, helps an allergist sort out which it was. A technician records what the patient reports and passes it on. The technician does not decide whether something is "really" an allergy.

Azithromycin. The serious effects MedlinePlus lists include:

a fast, pounding or irregular heartbeat
blistering or peeling skin
severe watery or bloody diarrhea, which may happen up to 2 months or more after treatment
yellowing of the skin or eyes

The patient should also tell the doctor about any personal or family history of a prolonged QT interval, a rare heart-rhythm problem.

Inhaled corticosteroids. These monographs list several items that need the doctor's attention:

white spots or sores in the mouth (listed as serious for budesonide)
vision changes
for patients switching from an oral steroid, symptoms such as extreme tiredness, weakness, dizziness or fainting

The budesonide monograph also says to rinse the mouth with water and spit after each treatment. Treat that as a budesonide instruction. The fluticasone monograph supplied here does not state it.

Tiotropium. Its uncommon serious effects include eye pain, blurred vision, seeing halos, painful or difficult urination, and a fast heartbeat.

These lists are examples, not a complete checklist. If a report doesn't match a listed sign, that doesn't mean it isn't urgent. When a report sounds serious, route it.

A symptom during treatment does not prove the drug caused it

Suppose a patient taking both montelukast and azithromycin reports feeling agitated. Agitation appears on montelukast's warning list. That makes the report important and urgent to pass on. It does not prove montelukast caused it, and it doesn't rule out other causes. Working out the cause belongs to the pharmacist and prescriber.

The technician's job is to pass along exactly what was reported, without labeling the cause. Reporting systems such as FDA MedWatch exist so that reports can be collected and studied. A single report is not proof of cause.

Question 7

A patient picking up azithromycin says, "Last time I took this I got nauseous and had diarrhea, so put me down as allergic." Using the ACAAI source, what should the technician understand, and what should they do?

Show answer and explanation

The ACAAI explains that side effects are often confused with true allergies. A true drug allergy involves the immune system. Nausea and diarrhea appear on its list of typical side effects. Even so, the technician should not decide whether this was an allergy or a side effect.

The useful action is to record exactly what the patient reports and bring the allergy question to the pharmacist. That means the symptoms, the medicine, and when it happened.

The tempting mistakes go both ways. One is labeling the patient allergic without information. The other is dismissing the report because it "sounds like a side effect."

Independent practice

Each case gives all the facts you need. Decide using only those facts.

Question 8

A patient's insurance will not pay for their fluticasone inhaler. A coworker says, "Budesonide is also an inhaled corticosteroid used to prevent asthma symptoms. Just switch it." What is wrong with this plan?

Show answer and explanation

A shared class and a shared use do not authorize a switch. Switching to a different medicine in the same class is therapeutic substitution, which the PTCE outline lists as an issue requiring pharmacist intervention.

The products also differ in specifics:

Budesonide comes as a powder inhaler or a nebulizer suspension. Each form has its own age range and directions.
Fluticasone schedules depend on the specific product.

Any change has to go through the pharmacist under your state's rules and site procedures.

Question 9

A patient using tiotropium capsules says, "I want to keep a capsule loaded in my inhaler so it's ready if I suddenly can't breathe." Name two problems with this plan, based on the source.

Show answer and explanation

Tiotropium is not for sudden attacks. MedlinePlus says not to use it for a sudden attack of wheezing or shortness of breath. The prescriber decides what to use for those.
Capsules must never be stored inside the inhaler. Blister packages should be opened only right before use.

Bring the plan to the pharmacist. The trap is assuming that a bronchodilator must be a rescue medicine.

Question 10

A parent picking up budesonide inhalation suspension for a 2-year-old asks whether they can squeeze an ampule into the child's juice, because the child dislikes the mask. What does the source say about this route, and who answers the parent?

Show answer and explanation

The suspension is meant to be inhaled as a mist from a jet nebulizer, and MedlinePlus says not to swallow it. Mixing it into a drink would change the route from inhalation to swallowing.

The parent's question about giving the medicine is a counseling matter for the pharmacist. Do not make up an alternative.

Question 11

A caller says their adult relative started montelukast recently. Since then, the relative has had unusual dreams and says they hear voices no one else hears. The caller asks whether this matters. What should the technician recognize, and how should it be handled?

Show answer and explanation

Unusual dreams and hallucinations, meaning seeing things or hearing voices that do not exist, are both listed in montelukast's serious mental-health warning. The source says to stop the medicine and call the doctor right away. Bring the pharmacist in immediately.

The call does not say whether there is any suicidal talk or immediate danger, so do not assume there isn't. If immediate danger or suicidal thoughts come up, follow emergency procedures: 911 for life-threatening situations, and 988 is available for crisis support.

The technician should not conclude that montelukast definitely caused the symptoms. The technician also should not reassure the caller that it is "probably fine."

Question 12

A patient taking azithromycin tablets also takes an antacid containing magnesium hydroxide. The patient asks the technician, "How many hours apart should I take them?" What does the source support, and what should happen?

Show answer and explanation

MedlinePlus says some time must pass between this kind of antacid and azithromycin. It tells patients to ask the doctor or pharmacist how many hours. It does not give a number.

The technician should not invent a time gap. This is an interaction question for the pharmacist. Recognizing a listed interaction is the technician's skill. Deciding the details is not.

What to remember

Inhaled corticosteroids (budesonide, fluticasone) reduce airway swelling and irritation with regular use to prevent asthma symptoms.
Montelukast is an oral leukotriene receptor antagonist. Its use determines its timing, and the limit is no more than one dose in 24 hours.
Tiotropium is a bronchodilator for COPD maintenance. Opening the airways does not make it a rescue medicine.
Azithromycin is a macrolide antibiotic. It acts on bacteria, not viruses or airway swelling, and it is taken as a finished course.
None of the four maintenance medicines is for a sudden attack. They build or keep control over time, and each label says so.
The product, not just the ingredient, sets the details. Form, device, age range, schedule, count and storage all come with the specific product.
Correct arithmetic, shared class or shared use does not authorize substitution or dispensing. Conflicts go to the pharmacist.
Listed interactions call for a handoff. Don't guess how the interaction works or how far apart to take the doses.
Warning lists are examples, not checklists. Breathing trouble, severe allergic signs or immediate danger call for emergency help. A symptom during treatment does not prove the drug caused it.